Net profit of Zydus Lifesciences declined 0.96% to Rs 1170.90 crore in the quarter ended March 2025 as against Rs 1182.30 crore during the previous quarter ended March 2024. Sales rose 17.21% to Rs 6290.20 crore in the quarter ended March 2025 as against Rs 5366.40 crore during the previous quarter ended March 2024.
For the full year,net profit rose 17.26% to Rs 4525.50 crore in the year ended March 2025 as against Rs 3859.50 crore during the previous year ended March 2024. Sales rose 18.68% to Rs 22573.80 crore in the year ended March 2025 as against Rs 19021.50 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 6290.20 | 5366.40 | 17 | 22573.80 | 19021.50 | 19 |
| OPM % | 33.79 | 30.38 | - | 31.27 | 28.31 | - |
| PBDT | 2129.50 | 1752.30 | 22 | 7162.10 | 5587.20 | 28 |
| PBT | 1891.60 | 1547.00 | 22 | 6246.30 | 4823.10 | 30 |
| NP | 1170.90 | 1182.30 | -1 | 4525.50 | 3859.50 | 17 |